Jasper Therapeutics is trading at $0.64 (-10.68%) amid renewed U.S.-Iran clashes, rising oil prices, and broader risk aversion.
- Biotech shares are under pressure, with XBI down 4.24% during the regular session.
- Major indexes are also lower as investors weigh geopolitical tensions, inflation concerns, higher yields, and fresh labor data.
- No clear company-specific announcement or catalyst was identified on September 1, 2026.